Document is current

Article History

Received: 10 November 2023

Accepted: 18 March 2024

First Online: 12 April 2024

Declarations

:

: The study protocol [CitationRef removed] was approved by Brightwater Care Group as a Level 2: Low Risk Study (Reference: 2021/BCG2110). This study is classed as internal service evaluation and quality assurance and does not require ethical approval for research in Australia. This aligns with the Australian Government’s National Health and Medical Research Council (NHMRC) policy exempting ethical review when data collected is used for identifying areas of improvement within the environment from where the data was collected [CitationRef removed].Participation was completely voluntary, and staff were free to decline participation. For interviews, staff were verbally invited to participate and verbal informed consent was obtained prior to each interview. At the end of each interview, participants were informed that they were able to withdraw their participation at any time by contacting the researchers to omit their responses from the analysis. For surveys, submission of survey responses was considered informed consent to use participant responses as part of the study. The online survey included a written Participant Information Sheet which informed participants they were able to withdraw their participation at any time by contacting the researchers using the contact details provided. Once a participant withdrew their consent, their responses were immediately deleted. A note was recorded against the participant’s ID code to indicate participant withdrawal. No personal identifiers were collected, and each participant was assigned an ID code during analysis and reporting.

: Not applicable.

: The authors declare no competing interests.